Mostrar el registro sencillo del ítem

dc.contributor.authorLópez-Baltanás, Rodrigo
dc.contributor.authorRodríguez-Ortiz, Maria E.
dc.contributor.authorDíaz Tocados, Juan Manuel
dc.contributor.authorMartínez-Moreno, Julio M.
dc.contributor.authorMembrives, Cristina
dc.contributor.authorRodelo Haad, Cristian Roberto
dc.contributor.authorPendón-Ruiz de Mier, María V.
dc.contributor.authorPendón-Ruiz de Mier, María V.
dc.contributor.authorRodríguez, Mariano
dc.contributor.authorCanalejo, Antonio
dc.contributor.authorAlmadén Peña, Yolanda
dc.contributor.authorMuñoz-Castañeda, Juan R.
dc.date.accessioned2023-01-31T13:44:57Z
dc.date.available2023-01-31T13:44:57Z
dc.date.issued2023
dc.identifier.urihttp://hdl.handle.net/10396/24590
dc.description.abstractwhether a dietary Mg supplementation might attenuate vascular dysfunction through the modulation of oxidative stress and inflammation in concurrent MetS and CKD. Methods: A rat model of MetS (Zucker strain) with CKD (5/6 nephrectomy, Nx) was used. Nephrectomized animals were fed a normal 0.1%Mg (MetS+Nx+Mg0.1%) or a supplemented 0.6%Mg (MetS+Nx+Mg0.6%) diet; Sham-operated rats with MetS receiving 0.1%Mg were used as controls. Results: As compared to controls, the MetS+Nx-Mg0.1% group showed a significant increase in oxidative stress and inflammation biomarkers (lipid peroxidation and aortic interleukin-1b and -6 expression) and Endothelin-1 levels, a decrease in nitric oxide and a worsening in uremia and MetS associated pathology as hypertension, and abnormal glucose and lipid profile. Moreover, proteomic evaluation revealed changes mainly related to lipid metabolism and CVD markers. By contrast, in the MetS+Nx+Mg0.6% group, these parameters remained largely similar to controls. Conclusion: In concurrent MetS and CKD, dietary Mg supplementation reduced inflammation and oxidative stress and improved vascular function.es_ES
dc.format.mimetypeapplication/pdfes_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightshttps://creativecommons.org/licenses/by/4.0/es_ES
dc.sourceAntioxidants, 12(2), 283; (2023)es_ES
dc.subjectMagnesiumes_ES
dc.subjectMetabolic syndromees_ES
dc.subjectChronic kidney diseasees_ES
dc.subjectInflammationes_ES
dc.subjectOxidative stresses_ES
dc.subjectVascular dysfunctiones_ES
dc.titleDietary Mg Supplementation Decreases Oxidative Stress, Inflammation, and Vascular Dysfunction in an Experimental Model of Metabolic Syndrome with Renal Failurees_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publisherversionhttps://doi.org/10.3390/antiox12020283es_ES
dc.relation.projectIDGobierno de España. PI20/0660 (FEDER)es_ES
dc.relation.projectIDGobierno de España. PI21/00654 (FEDER)es_ES
dc.relation.projectIDJunta de Andalucía. PI-0071-202es_ES
dc.relation.projectIDJunta de Andalucía. Y20_00773es_ES
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem